Table 2.
| a. Demographic characteristics of participants allocated at weeks 2 and 10a | |||||
|---|---|---|---|---|---|
| 1st allocation (week 2) | 2nd allocation (week 10) | ||||
| SC | TCM | SC | TCM | ||
| Number b | 40 | 39 | 43 | 42 | |
| Age | Years [Mean (SD)] | 42.3 (13.5) |
42.9 (13.0) |
43.7 (12.4) |
43.6 (12.0) |
| Percent | |||||
| Gender | Female | 85.0 | 87.2 | 86.0 | 88.1 |
| Ethnic Categories | Hispanic or Latino Not Hispanic or Latino Unknown (individuals not reporting ethnicity) |
10.0 85.0 5.0 |
10.3 84.6 5.2 |
11.6 88.4 0 |
11.9 83.3 4.8 |
| Racial Categories | White Non-white Unknown or not reported |
82.5 5.0 12.5 |
84.6 7.7 7.7 |
86.0 7.0 7.0 |
83.3 4.8 11.9 |
| Education | ≤High School Some College College graduate Post Graduate education |
12.5 37.5 25.0 25.0 |
7.7 38.5 28.2 25.6 |
14.0 23.8 28.6 33.3 |
21.3 31.0 19.1 28.6 |
| Marital Status | Married/ partnered Divorced/ Widowed/ Separated Never married/ partnered Not known |
37.5 27.5 35.0 0 |
59.0 10.2 30.8 0 |
46.5 30.2 23.3 0 |
54.8 21.4 23.8 0 |
| Income ($) | No response <25K 25–50K 50–100K >100K |
5.0 32.5 22.5 27.5 12.5 |
2.6 30.8 35.9 25.6 5.1 |
11.6 23.3 27.9 25.6 11.6 |
4.8 33.3 31.0 21.4 9.5 |
|
TCM differentiations (most salient) |
Liver Qi Constraint Qi & Blood Stagnation Other c |
47.5 37.5 15.0 |
53.8 38.5 7.7 |
34.9 51.2 13.9 |
47.6 38.1 14.3 |
| b Baseline Pain Characteristics for participants allocated at weeks 2 and 10 | |||||
|---|---|---|---|---|---|
| 1st allocation (week 2) | 2nd allocation (week 10) | ||||
| SC | TCM | SC | TCM | ||
| Number | 40 | 39 | 43 | 42 | |
| Variable | Mean (SD) | ||||
| Worst facial pain [0–10] | 8.1(1.4) | 8.1(1.2) | 7.5(1.5) | 7.6(1.5) | |
| Average facial pain [0–10] | 6.0(1.6) | 6.5(1.8) | 5.8(1.7) | 5.6(2.2) | |
| Facial pain today [0–10] | 5.0(2.0) | 5.3(2.2) | 4.5(2.2) | 4.5(2.3) | |
| Characteristic facial pain [0–10](mean of 3 above) | 6.4(1.4) | 6.6(1.4) | 5.9(1.5) | 5.8(2.0) | |
| Days of facial paina | 4.9(1.4) | 4.8(1.3) | 4.7(1.4) | 4.6(1.6) | |
| Amt. interferes with daily activities [0–10] | 4.3(2.3) | 3.8(2.6) | 3.5(2.2) | 3.8(2.7) | |
| Amt. interferes with social activities [0–10] | 3.8(2.5) | 3.3(2.8) | 3.0(2.1) | 3.3(2.7) | |
| Amt. interferes with ability to work [0–10] | 3.8(2.4) | 3.8(2.8) | 3.0(2.3) | 2.9(2.7) | |
| Depression [1–4] | 2.0 (0.8) | 1.8 (0.6) | 1.7 (0.6) | 1.8 (0.8) | |
| Sleep [1–4] | 2.8 (0.8) | 2.5 (0.8) | 2.7 (0.8) | 2.6 (0.8) | |
| N of medications | 2.2 (1.5) | 1.8 (1.5) | 1.8 (1.4) | 1.9 (1.6) | |
| AIOS [0–10] | 5.5 (2.1) | 5.6 (2.0) | 5.6 (1.9) | 5.9 (1.9) | |
| Percent | |||||
| Duration of pain | <1 year 1–10 years >10 years |
10.0 55.0 35.0 |
10.3 43.6 46.1 |
7.0 41.8 51.2 |
4.8 59.5 35.7 |
|
Visited a practitioner for pain treatment |
No Yes |
5.3 94.7 |
18.4 81.6 |
16.3 85.7 |
4.9 95.1 |
| Nature of facial pain | Continuous | 47.5 | 41.0 | 44.2 | 43.9 |
| Intermittent | 52.5 | 58.9 | 55.8 | 56.1 | |
| Graded Chronic Pain score | 0–2 3–4 |
30 70 |
35.9 64.1 |
37.2 62.8 |
42.8 57.1 |
|
TMD Diagnostic Groups (RDC-TMD Axis I) |
Group 1a 1b |
53 41 |
39 42 |
61 25 |
46 41 |
| Any Group 2 | 20 | 15 | 33 | 21 | |
| Group 3a 3b–c |
63 5 |
67 0 |
47 5 |
52 2 |
|
| Group 1 + 3a | 63 | 62 | 44 | 48 | |
a
None of the between-group differences within allocation periods are significant at p<.05.
b
Note that per design some of the same people are represented in the baselines for SC in period one, and SC and TCM in period 2.
c
Full details of other baseline differentiations are found in [39].
a
1 = 0–3d, 2 = 4–7d, 3 = 8–14d, 4 = 15–21d, 5 = 22–27d, 6 = every day (out of the past month)